XRPN closed down -50.32% (-$19.45) to $19.20 on Oct. 6 in the regular session, with after-hours trading slipping further near $18.80–$19.23. The drop marks a sharp reversal after a parabolic run-up, with shares surging roughly +273% last week to close at $39.42 (intraday high $53) on Oct. 2.

Nasdaq listing milestone: Trading under XRPN is expected to commence on October 8, 2026, following shareholder approval and the closing of the Evernorth business combination. XRP-centric balance sheet: At closing, Evernorth expects to hold roughly 473 million XRP, positioning it as the largest public company focused exclusively on an XRP treasury.

XRPN plunged roughly -51.44% during regular trading, falling from a $38.65 prior close to about $18.77 as its speculative run-up violently reversed. The decline follows a ~+273% surge last week into its pending merger with Ripple-backed XRP treasury firm Evernorth, triggering profit-taking as the deal nears its October 7 close.

Same issuer, different instruments: GPAT and GPATW are two classes of securities issued by the same company, GP-Act III Acquisition Corp., a special purpose acquisition company (SPAC) — a blank-check vehicle formed to merge with a private business. GPAT is the equity: Class A ordinary shares trade close to the cash value held in the company's trust account, giving them a relatively stable, downside-protected profile.

JACS is a healthcare-focused blank check company (a SPAC, or Special Purpose Acquisition Company) with no operating revenue, while JACS.RT represents the separate rights securities tied to the same vehicle. The two instruments carry very different risk profiles: JACS trades near its trust-backed redemption value, whereas JACS.RT is a low-priced, higher-volatility derivative-style security.

XRPN surged +86.09% during regular session trading, climbing from a $23.43 prior close to an intraday high near $43.60. The move was driven by its pending merger with Evernorth, a Ripple-backed XRP treasury firm, advancing toward a Nasdaq debut under the XRPN ticker.

FVNNU units surged +165.75% intraday to $31.89 from a $12.00 prior close, with gains building through the regular session. The rally triggered repeated LULD volatility trading halts as thin float and low volume amplified momentum.

Columbus Acquisition Corp (COLA) fell roughly 73% over the last 30 days, from about $10.67 at the September 2, 2026 close to $2.86 at the October 1, 2026 close. The decline was driven by the completion of its de-SPAC business combination with WISeSat.Space Holdings Corp, which closed on October 1, 2026.

XRPN (Armada Acquisition Corp. II) jumped +25.14% during regular trading hours on Sept 29, climbing from a $10.58 prior close to $13.24. The catalyst is the Sept 30 special shareholder vote on the merger with Evernorth, which would bring a managed XRP treasury (~473M XRP) onto Nasdaq under the XRPN ticker.

RILY closed down -3.85% at $5.49 during regular trading, slipping from a prior close of $5.71 on roughly average volume. The decline extends a prolonged slump for the heavily indebted financial conglomerate (now BRC Group Holdings), which carries roughly $2 billion in debt.

The central question is whether B. Riley Financial, Inc. (NASDAQ: RILY) can reclaim the widely watched $10 psychological level after trading near roughly $5.50 in recent sessions. The strongest bullish case rests on the stock's recent history: it traded above $11 within the past year, meaning $10 is not an abstract aspiration but a level the shares have already visited.

Rebrand and strategic pivot: The company formerly known as B. Riley Financial reorganized as BRC Group Holdings, signaling a shift toward a diversified holding structure spanning financial services, telecom, retail, and opportunistic investments. Deleveraging remains the central theme: Management reduced net debt to roughly $627 million by the end of 2025 and has identified further debt reduction as a 2026 priority, which could lower interest costs and improve financial flexibility.

IPEX shares fell roughly 70% over 30 days, from about $10.70 on August 26, 2026, to $3.16 at the September 25, 2026 close. The move accelerated as the special purpose acquisition company (SPAC) completed its business combination with GOWell Technology Limited on September 25, 2026.

HVIIU units declined roughly 57% over the past 30 days, from about $10.78 to $4.63, with most of the move concentrated in late September. The decline is structural rather than an earnings-driven selloff: Hennessy VII completed its business combination with ONE Nuclear Energy on September 23, 2026, and the combined company now trades under the ticker ONEN .

RACC shares fell roughly 58.7% over the past 30 days, sliding from about $26.50 in mid-August to near $10.95 as of mid-September. The drop unwound a sharp summer rally that carried the thinly traded U.S.-listed shares from around $11 in mid-July to an intraday peak above $33 in mid-August.

RACC surged approximately 128% over the past 30 days, driven by the announcement of a definitive business combination agreement with clinical-stage rare disease biotech Oak Hill Bio on July 27, 2026. The transaction is expected to provide Oak Hill Bio with roughly $175 million in gross proceeds, including $75 million from RACC's trust account fully backstopped by RA Capital Management and $100 million in committed private financing.

XXI plunged -14.1% during regular trading on Tuesday, falling from a prior close of $5.32 to approximately $4.57 as of late morning, with heavy selling volume. The primary catalyst: founder and CEO Jack Mallers stepped down effective July 20, replaced by board member Raphael Zagury, who leads Bitcoin mining firm Elektron Energy.

Shares of VACH are declining approximately 16.00% on Wednesday, May 13, 2026, falling from a Tuesday, May 12 close of $12.25 to approximately $10.29 — a continuation of extreme price volatility that triggered a trading halt for volatility on May 12 and reflects the structural mechanics of a near-empty SPAC (Special Purpose Acquisition Company) with only 82,685 public shares outstanding following a 99.67% shareholder redemption rate

Shares of RDAC are declining approximately 45.00% on Thursday, April 30, 2026, falling from a prior session close of approximately $20.51 to approximately $11.28 in a severe post-announcement reversal following an extraordinary 232%+ surge on April 29 driven by the company's confirmed SPAC merger transaction.

Lionheart Holdings (CUB) has traded quietly in recent sessions, reflecting the typical behavior of a SPAC still in its pre-merger search phase. Shares have hovered close to the company’s IPO price, supported by low volatility and thin trading volumes. This pattern mirrors broader trends across the SPAC market, where investor engagement often remains subdued until a definitive acquisition agreement is announced.